What Is Kiora Pharmaceuticals, Inc. (KPRX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Kiora Pharmaceuticals, Inc.'s intrinsic value is estimated at $4.75, presenting a divided outlook at the current price of $2.48. With an average implied return of +91.6% across a split 3–1 (bull–bear) consensus, the model spread of +434.5% underscores analytical uncertainty. Notably, First Chicago sees the most upside at +353.9% (fair value: $11.26), while ML-RIV is the most conservative at -80.6% ($0.48). The spread between these extremes — +434.5% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About KPRX?
6 of 13 models are currently active for KPRX. Of these, 5 models suggest upside while 1 model suggests overvaluation. See which stocks rank higher →
How Does KPRX Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, KPRX ranks #102 by Quality of Company score. CirclFi's QOC score of 6.3/10 evaluates 32 fundamental signals. A score of 6.3 indicates above-average quality.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a healthcare company, Kiora Pharmaceuticals, Inc. operates in a sector where revenue per drug is a critical driver of valuation. Investors evaluating KPRX should weigh these sector-specific dynamics alongside our model-derived fair values.
Is KPRX a Value Trap?
CirclFi's Value Trap algorithm assigns KPRX a score of 39/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
6 of 13 models are active for Kiora Pharmaceuticals, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Kiora Pharmaceuticals, Inc.'s fundamental quality profile registers 6.3/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +434.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every KPRX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across KPRX's 6 active models, average confidence is 37%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad